Donald P Carter, MD
Otolaryngology · Merced
- Medicare standing
- Clear
- Enrolled, allowed to bill and order, not excluded
- Plans that list them
- 9
- 1 carrier
- Offices
- 2
- Since medical school
- 35 years
- University of Kansas School of Med (Kc/Wich/Sal), 1991
Offices
2 locations · Dignity Health Medical Foundation · 1,211 clinicians in this group
Looking this up.
Hospitals listed: Mercy Medical Center. That is not proof they admit you there this week.
Plans that list them
9 plans · 1 carrier
A missing listing does not mean out of network. Directories change, and a listing does not cover every office. Call Dr. Carter’s office to confirm they take your plan. Ask about the office you use, its medical group, referrals and appointments.
| Alignment Health BreathEasy (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Clarity (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes CalPlus (HMO C-SNP) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health Heart & Diabetes Care (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Heart & Diabetes Choice (HMO C-SNP) | Alignment Health Plan | Listed | Sep 28, 2026 |
| Alignment Health Honor+ Plan (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health My Choice CalCare (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
| Alignment Health smartHMO (HMO) | Alignment Health Plan | Listed | Oct 3, 2026 |
California Medical Board record
Licence G70792 · Current
Licensed to practise in California · since 1991 · expires 2028-08-31 · Washington University School of Medicine.
No disciplinary actions, convictions, malpractice judgments or citations in this record.
Surgery centers they own
- UAS Management, Inc.Ambulatory Surgery Center · Merced, CA10% owner since 2002 · accredited by AAAHCAccreditation Renewed2 inspections · last 2016-05-03
Hospitals they work in
1 hospital
These rate the hospital, not this clinician. Most measures at most hospitals are no different from the national rate.
- Mercy Medical CenterMerced, CAAcute Care Hospital · Voluntary non-profit - Private · Has an emergency department · Birthing-friendlyPart of CommonSpirit Health, which runs 145 hospitals in 19 statesPatients rate it 3 of 5 · 59% would definitely recommend itOverall rating: 3 of 5 starsBetter than the national rate — Catheter Associated Urinary Tract Infections (ICU + select Wards): 0, Oct 2024 – Sep 2025Better than the national rate — Central Line Associated Bloodstream Infection (ICU + select Wards): 0.168, Oct 2024 – Sep 2025Better than the national rate — Clostridium Difficile (C.Diff): 0.364, Oct 2024 – Sep 2025
See every measure and the patient survey for Mercy Medical Center
Behind the star rating — Deaths: 0 better, 5 the same, 1 worse of 6 measures. Safety: 3 better, 3 the same, 0 worse of 6 measures. Readmissions: 0 better, 7 the same, 2 worse of 9 measures. The star rating is worked out from an earlier period than the measures below, so the two can disagree.
| Catheter Associated Urinary Tract Infections (ICU + select Wards)Infections | 0 | Better | Oct 2024 – Sep 2025 |
| Central Line Associated Bloodstream Infection (ICU + select Wards)Infections | 0.168 | Better | Oct 2024 – Sep 2025 |
| Clostridium Difficile (C.Diff)Infections | 0.364 | Better | Oct 2024 – Sep 2025 |
| Abdominopelvic accidental puncture or laceration rateComplications and deaths | 1.1 (0.11 to 2.09) · 798 cases | No different | Jul 2022 – Jun 2024 |
| CMS Medicare PSI 90: Patient safety and adverse events compositeComplications and deaths | 0.74 (0.37 to 1.11) | No different | Jul 2022 – Jun 2024 |
| Death rate for COPD patientsComplications and deaths | 7.7 · 165 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart attack patientsComplications and deaths | 11.7 · 69 cases | None | Jul 2022 – Jun 2025 |
| Death rate for heart failure patientsComplications and deaths | 11.3 · 449 cases | None | Jul 2022 – Jun 2025 |
| Death rate for pneumonia patientsComplications and deaths | 17.5 · 544 cases | None | Jul 2022 – Jun 2025 |
| Death rate for stroke patientsComplications and deaths | 11 · 206 cases | None | Jul 2023 – Jun 2025 |
| Hybrid Hospital-Wide All-Cause Risk Standardized Mortality RateComplications and deaths | 3.6 · 1,843 cases | None | Jul 2024 – Jun 2025 |
| Iatrogenic pneumothorax rateComplications and deaths | 0.16 (0 to 0.37) · 5,594 cases | No different | Jul 2022 – Jun 2024 |
| In-hospital fall-associated fracture rateComplications and deaths | 0.23 (0.03 to 0.43) · 5,647 cases | No different | Jul 2022 – Jun 2024 |
| Perioperative pulmonary embolism or deep vein thrombosis rateComplications and deaths | 2.53 (0.28 to 4.78) · 763 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative acute kidney injury requiring dialysis rateComplications and deaths | 1.64 (0 to 3.35) · 161 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative hemorrhage or hematoma rateComplications and deaths | 1.96 (0.37 to 3.55) · 791 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative respiratory failure rateComplications and deaths | 7.67 (0 to 16.88) · 163 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative sepsis rateComplications and deaths | 4.84 (0.67 to 9.02) · 115 cases | No different | Jul 2022 – Jun 2024 |
| Postoperative wound dehiscence rateComplications and deaths | 1.92 (0.46 to 3.38) · 273 cases | No different | Jul 2022 – Jun 2024 |
| Pressure ulcer rateComplications and deaths | 0.16 (0 to 0.85) · 4,979 cases | No different | Jul 2022 – Jun 2024 |
| MRSA BacteremiaInfections | 0 | No different | Oct 2024 – Sep 2025 |
| SSI - Colon SurgeryInfections | 0.764 | No different | Oct 2024 – Sep 2025 |
| Acute Myocardial Infarction (AMI) 30-Day Readmission RateUnplanned return visits | 14 · 31 cases | None | Jul 2023 – Jun 2025 |
| Heart failure (HF) 30-Day Readmission RateUnplanned return visits | 21.5 · 477 cases | None | Jul 2023 – Jun 2025 |
| Hospital return days for heart failure patientsUnplanned return visits | 62.8 · 511 cases | None | Jul 2022 – Jun 2025 |
| Hospital return days for pneumonia patientsUnplanned return visits | 43.6 · 554 cases | None | Jul 2022 – Jun 2025 |
| Pneumonia (PN) 30-Day Readmission RateUnplanned return visits | 18.8 · 462 cases | None | Jul 2023 – Jun 2025 |
| Rate of emergency department (ED) visits for patients receiving outpatient chemotherapyUnplanned return visits | 5.7 (3.8 to 8.2) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of inpatient admissions for patients receiving outpatient chemotherapyUnplanned return visits | 10.7 (8 to 14.1) · 152 cases | No different | Jan 2024 – Dec 2024 |
| Rate of readmission for chronic obstructive pulmonary disease (COPD) patientsUnplanned return visits | 19.9 · 196 cases | None | Jul 2023 – Jun 2025 |
| Rate of unplanned hospital visits after colonoscopy (per 1,000 colonoscopies)Unplanned return visits | 13.9 (10.2 to 19) · 70 cases | No different | Jan 2022 – Dec 2024 |
| Ratio of unplanned hospital visits after hospital outpatient surgeryUnplanned return visits | 1 (0.8 to 1.4) · 413 cases | No different | Jan 2024 – Dec 2024 |
What patients said (394 patients answered, 11% of those asked)
| Cleanliness | 4 |
| Nurse communication | 3 |
| Doctor communication | 2 |
| Communication about medicines | 3 |
| Discharge information | 3 |
| Overall hospital rating | 3 |
| Quietness | 3 |
| Recommend hospital | 2 |
| Room was "always" clean | 73% |
| Nurses "always" communicated well | 78% |
| Doctors "always" communicated well | 75% |
| Staff "always" explained | 61% |
| Yes, staff "did" give patients this information | 85% |
| Yes, staff "did" give patients information about help after discharge | 83% |
| Doctors "always" explained things so they could understand | 73% |
| Doctors "always" listened carefully | 72% |
| Doctors "always" treated them with courtesy and respect | 80% |
| Patients who gave a rating of "9" or "10" (high) | 64% |
| Staff "always" explained new medications | 74% |
| Nurses "always" explained things so they could understand | 74% |
| Nurses "always" listened carefully | 75% |
| Nurses "always" treated them with courtesy and respect | 85% |
| "Always" quiet at night | 49% |
| "YES", patients would definitely recommend the hospital | 59% |
| Staff "always" explained possible side effects | 49% |
| Yes, staff "did" give patients information about possible symptoms | 86% |
Original Medicare doctor bills
$235,634
Medicare paid this office $235,634 for 1,031 people.
This is what Medicare paid the clinician — not Medicare Advantage, and not the pharmacy.
| Return visit (30+ min) | 840 | $137,788 | $91 |
| Exam of ear using a microscope | 581 | $22,787 | $22 |
| New patient visit (45+ min) | 145 | $16,462 | $114 |
| Short return visit (20+ min) | 90 | $6,946 | $73 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $6,739 | $99 |
See all 14 services
| Return visit (30+ min) | 840 | $137,788 | $91 |
| Exam of ear using a microscope | 581 | $22,787 | $22 |
| New patient visit (45+ min) | 145 | $16,462 | $114 |
| Short return visit (20+ min) | 90 | $6,946 | $73 |
| Diagnostic exam of voice box using a flexible endoscope | 62 | $6,739 | $99 |
| Comprehensive hearing and speech recognition test | 253 | $6,553 | $25 |
| Test to assess middle ear function | 408 | $5,397 | $12 |
| New patient visit (30+ min) | 53 | $4,096 | $77 |
| Needle biopsy of thyroid through skin | 32 | $3,042 | $80 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 24 | $2,360 | $98 |
| Ultrasonic guidance for needle placement | 37 | $1,708 | $46 |
| Long return visit (40+ min) | 17 | $1,654 | $97 |
| Emergency department visit with low level of medical decision making | 23 | $1,471 | $53 |
| Repositioning exercises of head for treatment of dizziness, each day | 20 | $756 | $32 |
Procedures Medicare counted
| Removal of skin lesions | 1-10 | None |
| Skin biopsy | 1-10 | None |
| Upper gastrointestinal (GI) endoscopy for acid reflux | 1-10 | None |
Procedures year by year
| Procedure | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
| Diagnostic exam of voice box using a flexible endoscope | 105 | 99 | 111 | 80 | 77 | 68 |
| Needle biopsy of thyroid through skin | 60 | 49 | 34 | 41 | 46 | 38 |
| Punch biopsy, first skin growth | 12 | 12 | – | – | – | – |
Times billed to Original Medicare each year. A blank year means fewer than 11 people had it, or none: Medicare does not publish smaller counts. Medicare Advantage patients are not included.
Who their Medicare patients are
1,031 Original Medicare patients in 2024. Average age 77 · Under 65 5% · 85 and older 20% · Women 58% · Also on Medicaid 18% · Health risk score 1.19. At or below the middle of the specialty; the typical otolaryngology clinician is at 1.19.
Conditions among them: High blood pressure 75% · Diabetes 36% · Coronary heart disease 30% · Chronic kidney disease 23% · Atrial fibrillation 21% · COPD 19% · Heart failure 18% · Depression 13% · Cancer 11% · Stroke 9% · Dementia 7%.
The office billed $494,983, Medicare allowed $332,779 and paid $235,634; for 3,937 services of 60 kinds.
Original Medicare patients only. A risk score of 1.0 is the average Medicare patient; higher means sicker. Any count under 11 is hidden.
Year by year
| 2024 | 1,031 | 3,937 | 77 | 1.19 | $494,983 | $235,634 |
| 2023 | 1,157 | 4,403 | 76 | 1.14 | $569,920 | $269,946 |
| 2022 | 1,174 | 4,750 | 76 | 1.10 | $585,057 | $294,745 |
| 2021 | 1,180 | 4,710 | 76 | 1.18 | $556,605 | $299,519 |
| 2020 | 1,102 | 4,474 | 76 | 1.28 | $537,847 | $257,809 |
| 2019 | 1,123 | 4,317 | 76 | 1.39 | $510,297 | $235,694 |
| 2018 | 1,227 | 4,703 | 75 | 1.27 | $558,955 | $264,321 |
| 2017 | 1,500 | 5,808 | 75 | 1.34 | $627,973 | $303,184 |
| 2016 | 1,559 | 6,176 | 75 | 1.35 | $665,362 | $312,896 |
| 2015 | 1,592 | 6,522 | 75 | 1.31 | $744,426 | $347,169 |
| 2014 | 1,599 | 7,009 | 75 | 1.33 | $823,427 | $390,670 |
| 2013 | 1,458 | 5,823 | 75 | 1.30 | $701,619 | $338,040 |
Original Medicare only. A service billed for fewer than 11 people in a year is hidden, so the lines can add up to less than the year's total.
See the services billed each year
2023: 16 services
| Return visit (30+ min) | 831 | $134,295 | $94 |
| Exam of ear using a microscope | 632 | $23,076 | $23 |
| New patient visit (45+ min) | 124 | $15,299 | $123 |
| Comprehensive hearing and speech recognition test | 490 | $14,321 | $27 |
| New patient visit (30+ min) | 148 | $11,106 | $75 |
| Short return visit (20+ min) | 108 | $9,194 | $65 |
| Diagnostic exam of voice box using a flexible endoscope | 70 | $7,398 | $96 |
| Test to assess middle ear function | 498 | $6,850 | $12 |
| Needle biopsy of thyroid through skin | 36 | $3,736 | $81 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 33 | $3,593 | $103 |
| Long return visit (40+ min) | 19 | $2,629 | $138 |
| Ultrasonic guidance for needle placement | 43 | $2,026 | $46 |
| Ultrasound scan of head and neck soft tissue | 17 | $1,876 | $94 |
| Emergency department visit with low level of medical decision making | 28 | $1,830 | $55 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 15 | $1,752 | $63 |
| Exam of ear using a microscope | 17 | $136 | $8 |
2022: 17 services
| Return visit (30+ min) | 785 | $140,612 | $91 |
| Exam of ear using a microscope | 656 | $26,912 | $22 |
| New patient visit (30+ min) | 317 | $24,640 | $78 |
| Short return visit (20+ min) | 129 | $14,716 | $65 |
| Comprehensive hearing and speech recognition test | 411 | $11,870 | $26 |
| Diagnostic exam of voice box using a flexible endoscope | 68 | $7,537 | $94 |
| Test to assess middle ear function | 425 | $5,894 | $12 |
| Long return visit (40+ min) | 19 | $3,832 | $128 |
| Needle biopsy of thyroid through skin | 36 | $3,111 | $76 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 27 | $3,036 | $108 |
| New patient visit (45+ min) | 23 | $2,693 | $117 |
| Emergency department visit with low level of medical decision making | 27 | $1,783 | $58 |
| Ultrasonic guidance for needle placement | 39 | $1,634 | $42 |
| Ultrasound scan of head and neck soft tissue | 17 | $1,626 | $74 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 12 | $1,087 | $57 |
| Repositioning exercises of head for treatment of dizziness, each day | 21 | $755 | $31 |
| Exam of ear using a microscope | 18 | $136 | $8 |
2021: 17 services
| Return visit (30+ min) | 741 | $139,322 | $95 |
| New patient visit (30+ min) | 352 | $26,758 | $76 |
| Exam of ear using a microscope | 636 | $25,843 | $23 |
| Short return visit (20+ min) | 158 | $17,039 | $66 |
| Comprehensive hearing and speech recognition test | 449 | $13,848 | $29 |
| Diagnostic exam of voice box using a flexible endoscope | 98 | $10,621 | $96 |
| Long return visit (40+ min) | 43 | $9,345 | $133 |
| Test to assess middle ear function | 461 | $6,436 | $13 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 29 | $3,423 | $110 |
| Needle biopsy of thyroid through skin | 30 | $2,915 | $86 |
| New patient visit (45+ min) | 21 | $2,794 | $133 |
| Emergency department visit with low level of medical decision making | 27 | $1,750 | $58 |
| Ultrasonic guidance for needle placement | 32 | $1,466 | $44 |
| Ultrasound scan of head and neck soft tissue | 11 | $1,087 | $99 |
| Subsequent hospital care with moderate levelof medical decision making at least 35 minutes | 13 | $1,052 | $58 |
| Repositioning exercises of head for treatment of dizziness, each day | 18 | $698 | $37 |
| Exam of ear using a microscope | 19 | $140 | $7 |
2020: 16 services
| Return visit (30+ min) | 647 | $96,294 | $81 |
| New patient visit (30+ min) | 353 | $26,502 | $75 |
| Exam of ear using a microscope | 573 | $23,518 | $23 |
| Short return visit (20+ min) | 190 | $16,353 | $57 |
| Comprehensive hearing and speech recognition test | 467 | $14,143 | $28 |
| Long return visit (40+ min) | 50 | $10,821 | $112 |
| Diagnostic exam of voice box using a flexible endoscope | 88 | $9,043 | $91 |
| Test to assess middle ear function | 473 | $6,293 | $12 |
| Needle biopsy of thyroid through skin | 40 | $3,855 | $79 |
| New patient visit (45+ min) | 29 | $3,560 | $123 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 22 | $2,482 | $108 |
| Ultrasonic guidance for needle placement | 41 | $1,735 | $41 |
| Emergency department visit with low level of medical decision making | 21 | $1,213 | $51 |
| Punch biopsy, first skin growth | 11 | $1,175 | $98 |
| Repositioning exercises of head for treatment of dizziness, each day | 12 | $523 | $37 |
| Exam of ear using a microscope | 22 | $174 | $8 |
2019: 16 services
| Return visit (30+ min) | 674 | $94,816 | $78 |
| New patient visit (30+ min) | 301 | $22,686 | $75 |
| Exam of ear using a microscope | 577 | $21,598 | $22 |
| Short return visit (20+ min) | 194 | $14,479 | $50 |
| Comprehensive hearing and speech recognition test | 460 | $13,024 | $27 |
| Diagnostic exam of voice box using a flexible endoscope | 87 | $8,212 | $78 |
| Test to assess middle ear function | 461 | $5,569 | $11 |
| Long return visit (40+ min) | 38 | $5,142 | $112 |
| Needle biopsy of thyroid through skin | 47 | $4,492 | $75 |
| New patient visit (45+ min) | 31 | $3,297 | $106 |
| Ultrasonic guidance for needle placement | 52 | $2,094 | $40 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 19 | $2,008 | $106 |
| Punch biopsy, first skin growth | 12 | $1,112 | $93 |
| Emergency department visit with low level of medical decision making | 13 | $616 | $47 |
| Repositioning exercises of head for treatment of dizziness, each day | 13 | $562 | $33 |
| Exam of ear using a microscope | 14 | $97 | $7 |
2018: 17 services
| Return visit (30+ min) | 621 | $89,055 | $80 |
| Short return visit (20+ min) | 350 | $27,304 | $53 |
| New patient visit (30+ min) | 325 | $24,735 | $76 |
| Exam of ear using a microscope | 540 | $22,834 | $23 |
| Comprehensive hearing and speech recognition test | 504 | $15,044 | $28 |
| Long return visit (40+ min) | 83 | $11,125 | $114 |
| Diagnostic exam of voice box using a flexible endoscope | 83 | $8,291 | $88 |
| Test to assess middle ear function | 509 | $5,922 | $11 |
| New patient visit (45+ min) | 49 | $5,885 | $120 |
| Needle biopsy of thyroid through skin | 39 | $3,314 | $77 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 26 | $2,810 | $108 |
| Ultrasonic guidance for needle placement | 45 | $1,947 | $42 |
| Biopsy of single growth of skin and/or tissue | 17 | $1,151 | $68 |
| Ultrasound scan of head and neck soft tissue | 11 | $1,070 | $97 |
| Emergency department visit with low level of medical decision making | 20 | $1,014 | $48 |
| Repositioning exercises of head for treatment of dizziness, each day | 17 | $615 | $32 |
| Exam of ear using a microscope | 13 | $106 | $8 |
2017: 21 services
| Short return visit (20+ min) | 1,072 | $110,878 | $54 |
| New patient visit (30+ min) | 478 | $37,049 | $78 |
| Exam of ear using a microscope | 698 | $27,360 | $23 |
| Comprehensive hearing and speech recognition test | 557 | $17,026 | $29 |
| Return visit (30+ min) | 153 | $13,355 | $82 |
| Diagnostic exam of voice box using a flexible endoscope | 104 | $10,312 | $89 |
| Test to assess middle ear function | 575 | $7,005 | $11 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 12 | $6,679 | $557 |
| Removal of thyroid lobe on side of neck | 11 | $5,606 | $510 |
| Initial hospital care with straightforward or low-level medical decision making at least 55 minutes | 43 | $4,870 | $111 |
| Needle biopsy of thyroid through skin | 50 | $4,844 | $78 |
| Diagnostic exam of nasal passages using an endoscope | 24 | $4,103 | $147 |
| Complex control of nose bleed | 11 | $2,752 | $183 |
| Ultrasonic guidance for needle placement | 50 | $2,276 | $45 |
| Biopsy of single growth of skin and/or tissue | 23 | $1,984 | $86 |
| Ultrasound scan of head and neck soft tissue | 22 | $1,910 | $87 |
| New patient visit (45+ min) | 14 | $1,626 | $116 |
| New patient visit (15+ min) | 20 | $1,112 | $56 |
| Short return visit | 28 | $1,046 | $35 |
| Emergency department visit with low level of medical decision making | 11 | $544 | $49 |
| Exam of ear using a microscope | 30 | $249 | $8 |
2016: 21 services
| Short return visit (20+ min) | 1,097 | $118,595 | $53 |
| New patient visit (30+ min) | 508 | $36,763 | $72 |
| Exam of ear using a microscope | 688 | $24,909 | $23 |
| Comprehensive hearing and speech recognition test | 663 | $19,501 | $27 |
| Diagnostic exam of voice box using a flexible endoscope | 113 | $11,742 | $89 |
| Return visit (30+ min) | 96 | $8,832 | $83 |
| Test to assess middle ear function | 680 | $8,436 | $11 |
| Removal of thyroid lobe on side of neck | 12 | $6,684 | $557 |
| Needle biopsy of thyroid through skin | 43 | $4,006 | $79 |
| Complex control of nose bleed | 14 | $3,543 | $177 |
| Simple removal of skin debris and drainage of mastoid cavity | 18 | $2,544 | $82 |
| Diagnostic exam of nasal passages using an endoscope | 16 | $2,316 | $129 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 30 | $2,291 | $76 |
| New patient visit (45+ min) | 19 | $2,212 | $116 |
| Ultrasound scan of head and neck soft tissue | 19 | $1,763 | $93 |
| Ultrasonic guidance for needle placement | 37 | $1,654 | $45 |
| Biopsy of single growth of skin and/or tissue | 22 | $1,641 | $75 |
| New patient visit (15+ min) | 35 | $1,596 | $46 |
| Repositioning exercises of head for treatment of dizziness, each day | 17 | $729 | $29 |
| Short return visit | 16 | $492 | $31 |
| Exam of ear using a microscope | 18 | $138 | $8 |
2015: 22 services
| Short return visit (20+ min) | 1,167 | $121,917 | $52 |
| New patient visit (30+ min) | 461 | $34,771 | $75 |
| Exam of ear using a microscope | 720 | $26,195 | $23 |
| Comprehensive hearing and speech recognition test | 619 | $18,605 | $28 |
| Diagnostic exam of voice box using a flexible endoscope | 109 | $11,571 | $90 |
| Return visit (30+ min) | 110 | $10,344 | $81 |
| Test to assess middle ear function | 639 | $8,317 | $11 |
| Ultrasound scan of head and neck soft tissue | 70 | $7,438 | $94 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 12 | $6,692 | $515 |
| Needle biopsy of thyroid through skin | 57 | $6,075 | $88 |
| Simple removal of skin debris and drainage of mastoid cavity | 24 | $4,072 | $102 |
| New patient visit (15+ min) | 74 | $3,927 | $53 |
| Ultrasonic guidance for needle placement | 57 | $2,997 | $48 |
| Biopsy of single growth of skin and/or tissue | 37 | $2,729 | $70 |
| Complex control of nose bleed | 14 | $2,706 | $169 |
| Diagnostic exam of nasal passages using an endoscope | 13 | $2,202 | $130 |
| New patient visit (45+ min) | 16 | $1,895 | $118 |
| Short return visit | 54 | $1,886 | $34 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 19 | $1,481 | $78 |
| Emergency department visit with low level of medical decision making | 19 | $833 | $42 |
| Repositioning exercises of head for treatment of dizziness, each day | 15 | $725 | $33 |
| Exam of ear using a microscope | 27 | $246 | $8 |
2014: 26 services
| Short return visit (20+ min) | 1,147 | $132,062 | $54 |
| New patient visit (30+ min) | 606 | $46,449 | $77 |
| Exam of ear using a microscope | 744 | $30,693 | $24 |
| Comprehensive hearing and speech recognition test | 655 | $20,047 | $29 |
| Return visit (30+ min) | 159 | $14,826 | $80 |
| Diagnostic exam of voice box using a flexible endoscope | 129 | $14,083 | $93 |
| Removal or exploration of parathyroid glands | 13 | $11,981 | $666 |
| Test to assess middle ear function | 661 | $8,465 | $12 |
| Ultrasound scan of head and neck soft tissue | 78 | $7,964 | $97 |
| Repair of wound of forehead, cheeks, chin, mouth, neck, underarms, genitals, hands, or feet by transferring skin, 10.0 sq cm or less | 13 | $7,343 | $490 |
| Repair of wound of eyelids, nose, ears, or lips by transferring skin, 10.0 sq cm or less | 11 | $6,621 | $552 |
| Needle biopsy of thyroid through skin | 61 | $6,335 | $87 |
| Simple removal of skin debris and drainage of mastoid cavity | 27 | $4,880 | $98 |
| Ultrasonic guidance for needle placement | 63 | $3,946 | $61 |
| Diagnostic exam of nasal passages using an endoscope | 14 | $3,213 | $124 |
| Incision of eardrum with insertion of eardrum tube under local or topical anesthesia | 11 | $2,379 | $183 |
| Biopsy of single growth of skin and/or tissue | 28 | $2,250 | $66 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 28 | $2,247 | $80 |
| New patient visit (45+ min) | 13 | $1,746 | $134 |
| New patient visit (15+ min) | 30 | $1,677 | $56 |
| Complex control of nose bleed | 12 | $1,552 | $119 |
| Evaluation and testing for balance with recording | 16 | $1,327 | $83 |
| Short return visit | 22 | $832 | $35 |
| Assessment and recording of balance system during irrigation of both ears | 18 | $811 | $12 |
| Repositioning exercises of head for treatment of dizziness, each day | 16 | $782 | $33 |
| Exam of ear using a microscope | 38 | $327 | $8 |
2013: 23 services
| Short return visit (20+ min) | 1,024 | $113,398 | $53 |
| New patient visit (30+ min) | 517 | $39,640 | $77 |
| Exam of ear using a microscope | 513 | $19,931 | $24 |
| Diagnostic exam of voice box using a flexible endoscope | 138 | $15,768 | $93 |
| Comprehensive hearing and speech recognition test | 493 | $15,010 | $28 |
| Return visit (30+ min) | 101 | $10,001 | $83 |
| Ultrasound scan of head and neck soft tissue | 72 | $7,297 | $99 |
| Test to assess middle ear function | 510 | $6,355 | $11 |
| Removal of thyroid lobe on side of neck | 11 | $5,952 | $541 |
| Simple removal of skin debris and drainage of mastoid cavity | 30 | $5,612 | $95 |
| Diagnostic exam of nasal passages using an endoscope | 26 | $3,950 | $123 |
| Short return visit | 98 | $3,624 | $33 |
| New patient visit (45+ min) | 28 | $3,547 | $127 |
| Needle biopsy or removal of surface lymph nodes | 31 | $3,503 | $97 |
| Biopsy of single growth of skin and/or tissue | 42 | $2,846 | $62 |
| New patient visit (15+ min) | 45 | $2,499 | $56 |
| Needle biopsy of thyroid through skin | 22 | $2,337 | $78 |
| Evaluation and testing for balance with recording | 22 | $1,824 | $83 |
| Initial hospital care with straightforward or low level of medical decision making, per day at least 40 minutes | 24 | $1,820 | $76 |
| Assessment and recording of balance system during irrigation of both ears | 23 | $1,066 | $13 |
| Repositioning exercises of head for treatment of dizziness, each day | 18 | $669 | $33 |
| Diagnostic exam of esophagus using a flexible endoscope through mouth | 12 | $515 | $43 |
| Exam of ear using a microscope | 21 | $165 | $7 |
Medicaid work
$49,719 in 2024
Medicaid paid $49,719 for 235 billed services this clinician did in 2024, up to 19 people in a month for one service.
Medicaid and CHIP claims where this clinician did the service, fee-for-service and managed care together. Any month with fewer than 11 patients is hidden, so small Medicaid practices undercount.
| Clinic visit/encounter, all-inclusive | 162 | $27,169 |
| Hearing aid, not otherwise classified | 14 | $18,500 |
| Return visit (30+ min) | 47 | $4,050 |
| Short return visit (20+ min) | 12 | $0 |
| 2024 | 235 | 4 | 19 | $49,719 |
| 2023 | 395 | 8 | 37 | $53,254 |
| 2022 | 729 | 7 | 46 | $110,916 |
| 2021 | 924 | 6 | 46 | $72,336 |
| 2020 | 500 | 6 | 53 | $42,733 |
| 2019 | 740 | 7 | 41 | $106,178 |
| 2018 | 618 | 6 | 44 | $89,393 |
See the largest Medicaid services in earlier years
2023
| Clinic visit/encounter, all-inclusive | 209 | $33,646 |
| Hearing aid, not otherwise classified | 12 | $15,864 |
| Return visit (30+ min) | 49 | $1,578 |
| Comprehensive audiometry threshold evaluation and speech recognition | 27 | $973 |
| Ear mold/insert, not disposable, any type | 15 | $745 |
| TYMPANOMETRY | 28 | $448 |
| New patient visit (30+ min) | 17 | $0 |
| Short return visit (20+ min) | 38 | $0 |
2022
| Hearing aid, not otherwise classified | 39 | $56,468 |
| Clinic visit/encounter, all-inclusive | 327 | $51,361 |
| Comprehensive audiometry threshold evaluation and speech recognition | 51 | $1,717 |
| TYMPANOMETRY | 51 | $744 |
| Ear mold/insert, not disposable, any type | 13 | $626 |
| New patient visit (30+ min) | 102 | $0 |
| Short return visit (20+ min) | 146 | $0 |
2021
| Clinic visit/encounter, all-inclusive | 463 | $70,473 |
| Comprehensive audiometry threshold evaluation and speech recognition | 27 | $960 |
| Ear mold/insert, not disposable, any type | 12 | $506 |
| TYMPANOMETRY | 27 | $396 |
| New patient visit (30+ min) | 152 | $0 |
| Short return visit (20+ min) | 243 | $0 |
2020
| Clinic visit/encounter, all-inclusive | 278 | $41,670 |
| Comprehensive audiometry threshold evaluation and speech recognition | 16 | $532 |
| Binocular microscopy | 16 | $332 |
| TYMPANOMETRY | 16 | $199 |
| New patient visit (30+ min) | 119 | $0 |
| Short return visit (20+ min) | 55 | $0 |
2019
| Clinic visit/encounter, all-inclusive | 368 | $54,972 |
| Hearing aid, not otherwise classified | 26 | $35,665 |
| Short return visit (20+ min) | 210 | $10,504 |
| New patient visit (30+ min) | 72 | $2,782 |
| Ear mold/insert, not disposable, any type | 24 | $1,281 |
| Comprehensive audiometry threshold evaluation and speech recognition | 14 | $561 |
| TYMPANOMETRY | 26 | $412 |
2018
| Clinic visit/encounter, all-inclusive | 362 | $52,661 |
| Hearing aid, not otherwise classified | 12 | $17,614 |
| Short return visit (20+ min) | 159 | $12,167 |
| New patient visit (30+ min) | 55 | $6,141 |
| Comprehensive audiometry threshold evaluation and speech recognition | 15 | $583 |
| TYMPANOMETRY | 15 | $228 |
Drugs they prescribed that Part D paid
$24,514
Pharmacies billed $24,514 in 2024.
This is pharmacy cost, not the office bill, and not what patients paid.
Opioids were 2% of their Part D prescriptions (19 of 1,148) in 2024. At or below the middle of the specialty; the typical otolaryngology clinician is at 4%.
937 generic and 211 brand-name prescriptions · $24,514 in drug cost · 38 antibiotic prescriptions to 37 people.
Part D prescriptions only. The opioid rate is opioid prescriptions as a share of all this clinician's Part D prescriptions; surgeons and pain specialists run higher than others, so it is shown against the same specialty.
| Azelastine | 147 | $6,109 | $42 |
| Levothyroxine | 494 | $5,505 | $11 |
| Synthroid | 65 | $4,197 | $65 |
| Fluticasone Propionate | 127 | $2,611 | $21 |
| Ciprofloxacin-Dexamethasone | 18 | $1,956 | $109 |
See all 14 drugs
| Azelastine | 147 | $6,109 | $42 |
| Levothyroxine | 494 | $5,505 | $11 |
| Synthroid | 65 | $4,197 | $65 |
| Fluticasone Propionate | 127 | $2,611 | $21 |
| Ciprofloxacin-Dexamethasone | 18 | $1,956 | $109 |
| Famotidine | 90 | $1,322 | $15 |
| Liothyronine | 35 | $1,321 | $38 |
| Omeprazole | 14 | $158 | $11 |
| Clotrimazole-Betamethasone | 12 | $118 | $10 |
| Triamcinolone Acetonide | 30 | $99 | $3 |
| Cephalexin | 20 | $94 | $5 |
| Azithromycin | 11 | $87 | $8 |
| Ondansetron Odt | 16 | $77 | $5 |
| Hydrocodone-Acetaminophen | 17 | $65 | $4 |
Year by year
| 2024 | 1,148 | 326 | 2% (19) | 18% | $24,514 |
| 2023 | 1,149 | 345 | 3% (35) | 18% | $28,614 |
| 2022 | 1,249 | 371 | 4% (46) | 24% | $30,238 |
| 2021 | 1,178 | 357 | 3% (30) | 28% | $34,887 |
| 2020 | 1,250 | 332 | 2% (26) | 38% | $35,210 |
| 2019 | 1,215 | 302 | 2% (19) | 31% | $28,068 |
| 2018 | 1,383 | 324 | 3% (36) | 29% | $28,081 |
| 2017 | 1,392 | 304 | 3% (39) | 31% | $27,919 |
| 2016 | 1,726 | 349 | 2% (41) | 27% | $37,397 |
| 2015 | 1,745 | 348 | 2% (42) | 25% | $35,967 |
| 2014 | 1,741 | 396 | 4% (69) | 25% | $42,210 |
| 2013 | 1,332 | 319 | 4% (59) | 24% | $39,092 |
Part D prescriptions only. A drug prescribed to fewer than 11 people in a year is hidden.
See the drugs prescribed each year
2023: 12 drugs
| Levothyroxine | 473 | $8,509 | $18 |
| Synthroid | 38 | $3,833 | $101 |
| Azelastine | 115 | $3,824 | $33 |
| Fluticasone Propionate | 152 | $3,012 | $20 |
| Ciprofloxacin-Dexamethasone | 16 | $2,670 | $167 |
| Famotidine | 128 | $2,519 | $20 |
| Liothyronine | 23 | $1,026 | $45 |
| Cephalexin | 38 | $301 | $8 |
| Omeprazole | 14 | $197 | $14 |
| Hydrocodone-Acetaminophen | 35 | $157 | $4 |
| Ondansetron Odt | 21 | $98 | $5 |
| Triamcinolone Acetonide | 19 | $50 | $3 |
2022: 16 drugs
| Levothyroxine | 470 | $9,077 | $19 |
| Synthroid | 55 | $4,377 | $80 |
| Azelastine | 93 | $3,710 | $40 |
| Ciprofloxacin-Dexamethasone | 19 | $3,015 | $159 |
| Fluticasone Propionate | 173 | $2,646 | $15 |
| Famotidine | 119 | $2,003 | $17 |
| Liothyronine | 24 | $1,253 | $52 |
| Ofloxacin | 15 | $644 | $43 |
| Clotrimazole | 12 | $545 | $45 |
| Cephalexin | 57 | $394 | $7 |
| Hydrocodone-Acetaminophen | 46 | $318 | $7 |
| Omeprazole | 18 | $258 | $14 |
| Euthyrox | 21 | $251 | $12 |
| Ondansetron Odt | 24 | $154 | $6 |
| Azithromycin | 14 | $87 | $6 |
| Triamcinolone Acetonide | 17 | $50 | $3 |
2021: 15 drugs
| Levothyroxine | 434 | $9,660 | $22 |
| Synthroid | 65 | $4,663 | $72 |
| Famotidine | 138 | $3,563 | $26 |
| Ciprofloxacin-Dexamethasone | 19 | $3,461 | $182 |
| Azelastine | 78 | $3,303 | $42 |
| Fluticasone Propionate | 128 | $2,363 | $18 |
| Liothyronine | 28 | $1,898 | $68 |
| Ofloxacin | 25 | $960 | $38 |
| Omeprazole | 17 | $431 | $25 |
| Nystatin | 13 | $299 | $23 |
| Cephalexin | 43 | $244 | $6 |
| Hydrocodone-Acetaminophen | 30 | $216 | $7 |
| Euthyrox | 26 | $139 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $71 | $6 |
| Triamcinolone Acetonide | 24 | $53 | $2 |
2020: 14 drugs
| Levothyroxine | 564 | $11,647 | $21 |
| Synthroid | 68 | $4,470 | $66 |
| Ciprodex | 15 | $3,792 | $253 |
| Famotidine | 129 | $2,285 | $18 |
| Fluticasone Propionate | 132 | $2,239 | $17 |
| Ofloxacin | 42 | $1,935 | $46 |
| Azelastine | 36 | $1,393 | $39 |
| Liothyronine | 29 | $1,011 | $35 |
| Omeprazole | 52 | $871 | $17 |
| Nystatin | 12 | $183 | $15 |
| Hydrocodone-Acetaminophen | 26 | $162 | $6 |
| Cephalexin | 27 | $125 | $5 |
| Triamterene-Hydrochlorothiazid | 12 | $89 | $7 |
| Triamcinolone Acetonide | 15 | $41 | $3 |
2019: 11 drugs
| Levothyroxine | 559 | $11,434 | $20 |
| Synthroid | 60 | $3,257 | $54 |
| Fluticasone Propionate | 139 | $2,185 | $16 |
| Azelastine | 34 | $1,964 | $58 |
| Liothyronine | 37 | $1,386 | $37 |
| Famotidine | 122 | $1,300 | $11 |
| Omeprazole | 77 | $1,008 | $13 |
| Ofloxacin | 23 | $851 | $37 |
| Cephalexin | 27 | $153 | $6 |
| Triamcinolone Acetonide | 18 | $97 | $5 |
| Hydrocodone-Acetaminophen | 19 | $77 | $4 |
2018: 12 drugs
| Levothyroxine | 660 | $10,939 | $17 |
| Synthroid | 59 | $2,795 | $47 |
| Fluticasone Propionate | 150 | $2,073 | $14 |
| Azelastine | 42 | $1,926 | $46 |
| Ofloxacin | 17 | $1,586 | $93 |
| Liothyronine | 40 | $1,400 | $35 |
| Omeprazole | 88 | $1,063 | $12 |
| Famotidine | 103 | $755 | $7 |
| Cephalexin | 38 | $275 | $7 |
| Hydrocodone-Acetaminophen | 31 | $212 | $7 |
| Azithromycin | 14 | $89 | $6 |
| Triamcinolone Acetonide | 13 | $45 | $3 |
2017: 13 drugs
| Levothyroxine | 682 | $10,591 | $16 |
| Fluticasone Propionate | 171 | $2,286 | $13 |
| Liothyronine | 58 | $1,746 | $30 |
| Synthroid | 37 | $1,542 | $42 |
| Azelastine | 30 | $1,541 | $51 |
| Omeprazole | 97 | $1,004 | $10 |
| Famotidine | 72 | $540 | $7 |
| Montelukast | 17 | $313 | $18 |
| Hydrocodone-Acetaminophen | 32 | $217 | $7 |
| Lansoprazole | 11 | $196 | $18 |
| Triamcinolone Acetonide | 14 | $175 | $12 |
| Cephalexin | 37 | $161 | $4 |
| Azithromycin | 13 | $74 | $6 |
2016: 18 drugs
| Levothyroxine | 859 | $12,952 | $15 |
| Dexilant | 12 | $2,855 | $238 |
| Azelastine | 62 | $2,816 | $45 |
| Fluticasone Propionate | 165 | $2,296 | $14 |
| Liothyronine | 72 | $1,461 | $20 |
| Synthroid | 39 | $1,283 | $33 |
| Omeprazole | 108 | $1,258 | $12 |
| Famotidine | 90 | $928 | $10 |
| Tobramycin-Dexamethasone | 11 | $899 | $82 |
| Hydrocodone-Acetaminophen | 35 | $714 | $20 |
| Nystatin | 26 | $598 | $23 |
| Montelukast | 11 | $420 | $38 |
| Calcitriol | 19 | $346 | $18 |
| Cephalexin | 41 | $197 | $5 |
| Methimazole | 18 | $194 | $11 |
| Ciprofloxacin | 15 | $134 | $9 |
| Triamcinolone Acetonide | 15 | $128 | $9 |
| Azithromycin | 11 | $62 | $6 |
2015: 18 drugs
| Levothyroxine | 791 | $11,087 | $14 |
| Dexilant | 13 | $4,191 | $322 |
| Fluticasone Propionate | 172 | $2,251 | $13 |
| Ciprodex | 13 | $2,219 | $171 |
| Omeprazole | 186 | $2,079 | $11 |
| Liothyronine | 88 | $1,580 | $18 |
| Tobramycin-Dexamethasone | 15 | $1,334 | $89 |
| Azelastine | 23 | $1,122 | $49 |
| Calcitriol | 38 | $1,032 | $27 |
| Synthroid | 26 | $931 | $36 |
| Famotidine | 109 | $823 | $8 |
| Nystatin | 28 | $662 | $24 |
| Hydrocodone-Acetaminophen | 33 | $307 | $9 |
| Methimazole | 17 | $225 | $13 |
| Cephalexin | 46 | $201 | $4 |
| Ciprofloxacin | 11 | $81 | $7 |
| Azithromycin | 12 | $71 | $6 |
| Amoxicillin | 12 | $62 | $5 |
2014: 18 drugs
| Levothyroxine | 676 | $8,127 | $12 |
| Ciprodex | 48 | $7,543 | $157 |
| Nexium | 22 | $5,926 | $269 |
| Fluticasone Propionate | 235 | $3,687 | $16 |
| Omeprazole | 144 | $2,135 | $15 |
| Liothyronine | 65 | $1,263 | $19 |
| Azelastine | 18 | $1,178 | $65 |
| Synthroid | 38 | $1,164 | $31 |
| Famotidine | 138 | $1,120 | $8 |
| Hydrocodone-Acetaminophen | 65 | $825 | $13 |
| Calcitriol | 21 | $517 | $25 |
| Nystatin | 18 | $472 | $26 |
| Methimazole | 19 | $382 | $20 |
| Triamcinolone Acetonide | 24 | $284 | $12 |
| Clotrimazole | 14 | $216 | $15 |
| Cephalexin | 48 | $211 | $4 |
| Azithromycin | 14 | $136 | $10 |
| Ciprofloxacin | 14 | $72 | $5 |
2013: 16 drugs
| Nexium | 16 | $5,092 | $318 |
| Fluticasone Propionate | 186 | $4,309 | $23 |
| Ciprodex | 27 | $3,971 | $147 |
| Levothyroxine | 409 | $3,647 | $9 |
| Nasonex | 23 | $3,266 | $142 |
| Omeprazole | 139 | $3,086 | $22 |
| Calcitriol | 28 | $1,967 | $70 |
| Synthroid | 65 | $1,351 | $21 |
| Liothyronine | 30 | $1,098 | $37 |
| Famotidine | 89 | $1,008 | $11 |
| Triamcinolone Acetonide | 23 | $667 | $29 |
| Nystatin | 14 | $483 | $34 |
| Hydrocodone-Acetaminophen | 52 | $386 | $7 |
| Methimazole | 18 | $313 | $17 |
| Cephalexin | 49 | $288 | $6 |
| Ciprofloxacin | 16 | $100 | $6 |
Money from drug and device companies
$92 in 2025
| 2025 | 3 | 4 | None | $92 |
| 2024 | 2 | 6 | None | $96 |
| 2023 | 3 | 4 | None | $71 |
| 2022 | 2 | 2 | None | $46 |
| 2021 | 1 | 3 | None | $68 |
| 2020 | 1 | 2 | None | $39 |
| 2019 | 3 | 3 | None | $10,338 |
Paid work is consulting, speaking, honoraria and royalties, as opposed to meals and travel.
A payment is not proof that care is biased.
| GlaxoSmithKline | Nucala | $45 | 2 payments
|
| Genzyme | Dupixent | $30 | 1 payment
|
| Merck Sharp & Dohme | Bridion | $17 | 1 payment
|
See all 4 published payments
| GlaxoSmithKline | Meals · 2025-08-07 | Nucala | $23 |
| GlaxoSmithKline | Meals · 2025-03-27 | Nucala | $22 |
| Genzyme | Meals · 2025-03-20 | Dupixent | $30 |
| Merck Sharp & Dohme | Meals · 2025-03-05 | Bridion | $17 |
See earlier years (2024, 2023, 2022, 2021, 2020, 2019)
2024: $96
| GlaxoSmithKline | Nucala | $81 | 5 payments
|
| Aerin Medical | Vivaer Stylus | $14 | 1 payment
|
2023: $71
| Optinose US | Xhance | $29 | 2 payments
|
| Merck Sharp & Dohme | None | $23 | 1 payment
|
| Aerin Medical | Vivaer Stylus | $19 | 1 payment
|
2022: $46
| Acclarent | Trudi Nav Cable | $28 | 1 payment
|
| GlaxoSmithKline | Nucala | $18 | 1 payment
|
2021: $68
| Optinose US | Xhance | $68 | 3 payments
|
2020: $39
| OptiNose US | Xhance | $39 | 2 payments
|
2019: $10,338
| Olympus America | Celon System | $10,303 | 1 payment
|
| OptiNose US | Xhance | $22 | 1 payment
|
| Covidien LP | Truclear | $14 | 1 payment
|
Checkups this office reported
10 measures · 2023
Medicare asked this office to report how often certain checkups happened in 2023. This is not a grade for the doctor. A specialist’s patients may not need every screening.
- Medicare’s overall office score
- 87.5 / 100
- Scores the office’s reporting and systems. It is not a grade for how the doctor treats you.
| Appropriate Treatment for Upper Respiratory Infection (URI)As Medicare defines this measure | 100% | 20 |
| Asked about smokingPatients asked about tobacco, with help to quit if they smoke | 71%That's more than half. | 72 |
| Breast cancer screeningEligible women who got a mammogram | 0%That's few of the people this applied to. | 555 |
| Cervical cancer screeningEligible women who got a Pap or HPV test | 0%That's few of the people this applied to. | 454 |
| Checked for fall riskOlder patients screened for fall risk | 76%That's most of the people this applied to. | 1,209 |
| Closing the Referral Loop: Receipt of Specialist ReportAs Medicare defines this measure | 0% | 1,305 |
| Colon cancer screeningEligible adults who got a colon cancer test | 1%That's few of the people this applied to. | 1,174 |
| Medications listed in the chartVisits where the current medication list was documented | 100%That's most of the people this applied to. | 5,316 |
See the other 2 measures
| Screening for High Blood Pressure and Follow-Up DocumentedAs Medicare defines this measure | 18% | 2,545 |
| Weight checked, with a follow-up planPatients whose BMI was recorded and followed up if needed | 24%That's few of the people this applied to. | 2,189 |
What the office says it does
Boxes the office ticked on its Medicare worksheet for 2023. Nobody checks these.
- Provide 24/7 Access to MIPS Eligible Clinicians or Groups Who Have Real-Time Access to Patient's Medical Record
Professional record
- NPI
- 1083634364
- Licence
- CA G70792California G70792: Current · expires 2028-08-31
- Trained
- University of Kansas School of Med (Kc/Wich/Sal), 1991 · 35 years ago
- Gender
- Male
More record details
- Sole proprietor
- Yes
- Medicaid ID
- CA 00G707920
- Taxonomy
- Federal specialty code 207YX0007X (207YX0007X)
- Mailing address
- 3351 M St Ste 205, Merced, CA, 95348
- NPI first listed
- 2006-07-20
- NPI last updated
- 2025-10-23
- NPI record certified
- 2025-10-23
This is when the NPI record was last certified, not a medical board exam.
Extra NPI addresses: 315 Mercy Ave Ste 400, Merced, CA, 95340